# A Controlled Study on Pain Management With Injection of Botulinum Toxin for Glabellar Line Correction

> **NCT06161246** · PHASE4 · COMPLETED · sponsor: **Galderma R&D** · enrollment: 60 (actual)

## Conditions studied

- Injection Site Discomfort

## Interventions

- **DEVICE:** Vibrating Beauty Bar

## Key facts

- **NCT ID:** NCT06161246
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-23
- **Primary completion:** 2024-02-15
- **Final completion:** 2024-02-15
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-03-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06161246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06161246, "A Controlled Study on Pain Management With Injection of Botulinum Toxin for Glabellar Line Correction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06161246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*